This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (16)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in JAMA  Topic Collections  • Cardiovascular System  • Radiologic Imaging  • Renal Diseases  • Renal Diseases, Other  • Randomized Controlled Trial  • Angiology  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

A Randomized Trial

Somjot S. Brar, MD; Albert Yuh-Jer Shen, MD; Michael B. Jorgensen, MD; Adam Kotlewski, MD; Vicken J. Aharonian, MD; Natasha Desai, BS; Michael Ree, BS; Ahmed Ijaz Shah, MD; Raoul J. Burchette, MS

JAMA. 2008;300(9):1038-1046.

Context  Sodium bicarbonate has been suggested as a possible strategy for prevention of contrast medium–induced nephropathy, a common cause of renal failure associated with prolonged hospitalization, increased health care costs, and substantial morbidity and mortality.

Objective  To determine if sodium bicarbonate is superior to sodium chloride for preventing contrast medium–induced nephropathy in patients with moderate to severe chronic kidney dysfunction who are undergoing coronary angiography.

Design, Setting, and Patients  Randomized, controlled, single-blind study conducted between January 2, 2006, and January 31, 2007, and enrolling 353 patients with stable renal disease who were undergoing coronary angiography at a single US center. Included patients were 18 years or older and had an estimated glomerular filtration rate of 60 mL/min per 1.73 m² or less and 1 or more of diabetes mellitus, history of congestive heart failure, hypertension, or age older than 75 years.

Interventions  Patients were randomized to receive either sodium chloride (n = 178) or sodium bicarbonate (n = 175) administered at the same rate (3 mL/kg for 1 hour before coronary angiography, decreased to 1.5 mL/kg per hour during the procedure and for 4 hours after the completion of the procedure).

Main Outcome Measure  The primary end point was a 25% or greater decrease in the estimated glomerular filtration rate on days 1 through 4 after contrast exposure.

Results  Median patient age was 71 (interquartile range, 65-76) years, and 45% had diabetes mellitus. The groups were well matched for baseline characteristics. The primary end point was met in 13.3% of the sodium bicarbonate group and 14.6% of the sodium chloride group (relative risk, 0.94; 95% confidence interval, 0.55-1.60; P = .82). In patients randomized to receive sodium bicarbonate vs sodium chloride, the rates of death, dialysis, myocardial infarction, and cerebrovascular events did not differ significantly at 30 days (1.7% vs 1.7%, 0.6% vs 1.1%, 0.6% vs 0%, and 0% vs 2.2%, respectively) or at 30 days to 6 months (0.6% vs 2.3%, 0.6% vs 1.1%, 0.6% vs 2.3%, and 0.6% vs 1.7%, respectively) (P > .10 for all).

Conclusion  The results of this study do not suggest that hydration with sodium bicarbonate is superior to hydration with sodium chloride for the prevention of contrast medium–induced nephropathy in patients with moderate to severe chronic kidney disease who are undergoing coronary angiography.

Trial Registration  clinicaltrials.gov Identifier: NCT00312117

Author Affiliations: Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York (Dr Brar); Kaiser Permanente, Los Angeles (Drs Shen, Jorgensen, Kotlewski, Aharonian, and Shah and Ms Desai and Mr Ree) and Pasadena (Mr Burchette), California; and UCLA School of Medicine, Los Angeles (Drs Shen and Jorgensen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy
William Burgess, Gregory J. Merten, and Robert A. Rittase
JAMA. 2009;301(4):377.
EXTRACT | FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy
Bradley D. Shy, Amit Gupta, and Robert S. Hoffman
JAMA. 2009;301(4):377-378.
EXTRACT | FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy
Mehmet Kanbay, Benan Kasapoglu, and Ali Akcay
JAMA. 2009;301(4):378.
EXTRACT | FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy
Alberto Bouzas-Mosquera, José M. Vázquez-Rodríguez, and Jesús Peteiro
JAMA. 2009;301(4):378-379.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The year in interventional cardiology.
Dixon et al.
J Am Coll Cardiol 2009;53:2080-2097.
FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium-Induced Nephropathy
Burgess et al.
JAMA 2009;301:377-377.
FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium-Induced Nephropathy
Kanbay et al.
JAMA 2009;301:378-378.
FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium-Induced Nephropathy
Shy et al.
JAMA 2009;301:377-378.
FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium-Induced Nephropathy
Bouzas-Mosquera et al.
JAMA 2009;301:378-379.
FULL TEXT  

Kidney disease in cardiology
Herzog
Nephrol Dial Transplant 2009;24:34-37.
FULL TEXT  

Preventing Contrast-Induced Nephropathy
Journal Watch Hospital Medicine 2008;2008:1-1.
FULL TEXT  

Sodium Bicarbonate Does Not Prevent Contrast-Induced Nephropathy
JWatch Emergency Med. 2008;2008:4-4.
FULL TEXT  

All you need to read in the other general journals
BMJ 2008;337:a1594-a1594.
FULL TEXT